BioLineRx Ltd.
BLRX | TA
Overview
Corporate Details
- ISIN(s):
- US09071M2052 (+1 more)
- LEI:
- 529900AKIOSC15Y63R18
- Country:
- Israel
- Address:
- Modi'in Technology Park, 2 HaMa'ayan Street, 7177871 Modi'in
- Website:
- https://www.biolinerx.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
BioLineRx Ltd. develops and commercializes therapies for oncology and other critical diseases.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for BioLineRx Ltd..
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-14 16:01 |
Earnings Release
Second Quarter 2025 Financial Results and Provides Corporate Update
|
English | 375.7 KB | |
| 2025-08-14 16:01 |
Foreign Filer Report
Second Quarter 2025 Financial Results and Provides Corporate Update
|
English | 36.5 KB | |
| 2025-07-26 23:19 |
Prospectus
Immediate Report
|
English | 397.4 KB | |
| 2025-07-26 23:19 |
Prospectus
Immediate Report
|
English | 36.3 KB | |
| 2025-07-01 01:25 |
Foreign Filer Report
Immediate Report
|
English | 127.3 KB | |
| 2025-07-01 01:25 |
Foreign Filer Report
Immediate Report
|
English | 36.5 KB | |
| 2025-05-30 17:23 |
Foreign Filer Report
New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-L…
|
English | 153.1 KB | |
| 2025-05-30 17:23 |
Foreign Filer Report
New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-L…
|
English | 36.4 KB | |
| 2025-05-27 16:01 |
Foreign Filer Report
BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate U…
|
English | 430.8 KB | |
| 2025-05-27 16:01 |
Foreign Filer Report
BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate U…
|
English | 36.4 KB | |
| 2025-05-24 23:14 |
Proxy Solicitation & Information Statement
Immediate Report of Meeting to be held on June 29,2025,proxy statement
|
English | 160.1 KB | |
| 2025-05-24 23:14 |
Foreign Filer Report
Immediate Report of Meeting to be held on June 29,2025,proxy statement
|
English | 534.4 KB | |
| 2025-05-24 23:14 |
Pre-Annual General Meeting Information
Immediate Report of Meeting to be held on June 29,2025,proxy statement
|
English | 100.8 KB | |
| 2025-04-14 13:22 |
Prospectus
PROSPECTUS SUPPLEMENT
|
English | 415.1 KB | |
| 2025-04-14 13:22 |
Prospectus
PROSPECTUS SUPPLEMENT
|
English | 36.2 KB |
Automate Your Workflow. Get a real-time feed of all BioLineRx Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for BioLineRx Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Scandinavian ChemoTech AB | Sweden | CMOTEC | |
|
Scandion Oncology A/S | Denmark | SCOL | |
|
Scope Fluidics S.A. | Poland | SCP | |
|
Sensorion | France | ALSEN | |
|
SenzaGen AB | Sweden | SENZA | |
|
SoftOx Solutions AS | Norway | SOFTX | |
|
Spago Nanomedical AB | Sweden | SPAGO | |
/other/Spermosens_AB_publ-logo.jpg){kind=logo}
|
Spermosens AB (publ) | Sweden | SPERM | |
|
Spexis AG | Switzerland | SPEX | |
|
Sprint Bioscience | Sweden | SPRINT |